Search clinical trials for: Recombinant Humanized Monoclonal Antibody MIL62 Injection
Total 614 results
-
ImmuneMed, Inc.Completed
-
Shanghai Zhangjiang Biotechnology Limited CompanyCompleted
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedEosinophilic AsthmaUnited States, Belgium, Colombia, Hungary, Israel, Poland, Sweden, Argentina, Brazil, Canada, France, Mexico, Netherlands
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
PDL BioPharma, Inc.CompletedMultiple SclerosisUnited States, Canada
-
Shanghai Henlius BiotechRecruitingAge Related Macular DegenerationChina
-
Genor Biopharma Co., Ltd.Unknown
-
Henlix, IncUnknown
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Not yet recruiting
-
Revance Therapeutics, Inc.Syneos HealthCompletedCervical DystoniaUnited States, Spain, Germany, Austria, Poland, France, Canada, Czechia, United Kingdom
-
YM BioSciencesTerminated
-
CSL BehringCompleted
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.CompletedGlioblastoma | Gliosarcoma | Giant Cell GlioblastomaUnited States
-
Case Comprehensive Cancer CenterTerminatedGlioblastoma | Brain Tumor | GliosarcomaUnited States
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
ImmuneMed, Inc.Terminated
-
ImmuneMed, Inc.CompletedCOVID-19Italy, Russian Federation
-
Bio-Thera SolutionsTerminatedAdvanced Solid TumourAustralia
-
Assiut UniversityCompletedOvarian Neoplasms | Germ Cell Tumors | ImmunohistochemistryEgypt
-
Sinocelltech Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesUnknownMetastatic Colorectal CancerChina
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States, Taiwan, Australia
-
Shanghai Junshi Bioscience Co., Ltd.UnknownMelanoma | Urological CancerChina
-
Peking UniversityUnknown
-
Bio-Thera SolutionsZhejiang Tumor HospitalRecruiting
-
Merck KGaA, Darmstadt, GermanyTerminated
-
Zhejiang Cancer HospitalCompletedNasopharyngeal CarcinomaChina
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedEosinophilic AsthmaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Actinium PharmaceuticalsCompletedLeukemia | Myelodysplastic SyndromeUnited States
-
Hangzhou Hanx Biopharmaceuticals, Ltd.Wuhan Hanxiong Bioscience, Ltd.Active, not recruitingAdvanced Solid TumorsChina
-
RemeGen Co., Ltd.RecruitingGastric Cancer | HER2 Overexpressing Gastric CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Shandong New Time Pharmaceutical Co., LTDSun Yat-sen UniversityNot yet recruitingAdvanced Malignant Tumors
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Recruiting
-
Lee's Pharmaceutical LimitedNot yet recruiting
-
National Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Sinocelltech Ltd.Tianjin Medical University Cancer Institute and HospitalUnknownEsophageal Squamous Cell CarcinomaChina
-
YM BioSciencesCompletedRecurrent Diffuse Pontine GliomasUnited States, Canada, Israel
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Recurrent Adult Brain NeoplasmUnited States
-
Genentech, Inc.CompletedNeoplasmsUnited States, Spain, Belgium, Korea, Republic of, Canada, Australia, France
-
United BioPharmaNot yet recruiting
-
Sinocelltech Ltd.Unknown
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
Beijing Friendship HospitalEnrolling by invitation
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruiting
-
Henlix, IncUnknownHepatitis B, ChronicTaiwan
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell LymphomaUnited States